Enduragel - a Novel Therapeutic Filling Material for Treatment of Cerebral Aneurysms - Licensing Opportuity for Dublin City University - August 2017 front page preview

Enduragel - a Novel Therapeutic Filling Material for Treatment of Cerebral Aneurysms - Licensing Opportuity for Dublin City University - August 2017

Enduragel is a minimally invasive injectable hydrogel for the treatment of brain aneurysms and other vascular problems such as Arteriovenous Malformations (AVMs) and dural fistulas. It can be injected through micro-cathe...

pdf 205.7KB

Advancing the development of a novel compound for the treatment of inflammatory disease - Licensing Opportunity for Dublin City University - August 2017 front page preview

Advancing the development of a novel compound for the treatment of inflammatory disease - Licensing Opportunity for Dublin City University - August 2017

DCU and UCD have jointly identified a compound purified from a marine species that exerts potent anti-inflammatory activity. The mechanism of action has been elucidated and the team have shown that the intracellular targ...

pdf 287KB

ChemoGel - A thermoresponsive hydrogel for interventional oncology applications   Licensing Opportunity from RCSI June 2017 front page preview

ChemoGel - A thermoresponsive hydrogel for interventional oncology applications Licensing Opportunity from RCSI June 2017

Thermoresponsive hydrogels have attracted significant attention for drug delivery due to their ability to phase-transition from an injectable liquid at room temperatures to a solid gel at physiological temperatures. Howe...

pdf 507.4KB

PanaColl- A collagen-based scaffold for the delivery of antibiotics and enhancement of tissue regeneration Licensing Opportunity for RCSI June 2017 front page preview

PanaColl- A collagen-based scaffold for the delivery of antibiotics and enhancement of tissue regeneration Licensing Opportunity for RCSI June 2017

Osteomyelitis (OM) is an infection of bone caused by bacteria such as Staphylococcus Aureus (S. Aureus). The current gold standard treatment for chronic OM is debridement of the infected bone followed by administration o...

pdf 462.2KB

Objective medication adherence calculator A tool to aid patient adherence and optimise drug dosage Licensing Opportunity for RCSI June 2017 front page preview

Objective medication adherence calculator A tool to aid patient adherence and optimise drug dosage Licensing Opportunity for RCSI June 2017

Assessing adherence to medication is an essential element in the ongoing treatment of patients with chronic disease as well as in the development and trialling of new drugs. The current standard methods of adherence asse...

pdf 379.5KB